Article Details
Retrieved on: 2022-08-30 18:55:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's oral therapy saracatinib, now in a clinical trial, was found as effective as approved IPF therapies in several disease models.
Article found on: pulmonaryfibrosisnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here